Summary
Tatton-Brown Rahman Syndrome (TBRS), also known as DNMT3A Overgrowth Syndrome, is a rare genetic disorder caused by changes (variants) in the DNMT3A gene. People with TBRS usually have tall stature, increased weight, and/or a large head size (macrocephaly). Intellectual disability and unique facial features are also common. Symptoms and their severity can vary widely, even within the same family.
Description
TBRS is a syndrome characterized by overgrowth, intellectual disability, and differences in facial features.
- Subtypes: No formally recognized subtypes, but symptoms vary.
- Severity spectrum: Some people may live independently, while others may need lifelong supports for daily living.
- Is it life-threatening? TBRS itself is not usually fatal, but there may be risks due to linked health problems, including heart conditions or cancer.
Signs and Symptoms
- Common symptoms:
- Tall height and/or large head size
- Overweight or obesity
- Intellectual disability (usually mild to moderate)
- Distinctive facial features: round face, thick/horizontal eyebrows, narrow eye openings, prominent upper front teeth
- Speech, learning, and motor delays
- Behavioral challenges and psychiatric issues: autism spectrum disorder, anxiety, depression, ADHD, aggression
- Joint hypermobility (looseness/double-jointedness)
- Hypotonia (low muscle tone – “floppiness”)
- Kyphoscoliosis (curved spine)
- Seizures
- Heart defects
- Subtle or less common signs:
- Cryptorchidism (undescended testicles in males)
- Ventriculomegaly (enlarged ventricles of the brain)
- Gastrointestinal issues
- Skin issues (thin, delicate, easily bruising)
- Excessive hair
- Respiratory concerns
- Neurological disorders/Brain structure changes on imaging
- Cancer risk, especially acute myeloid leukemia (lower overall risk, but higher than general population).
Causes
- TBRS is caused by changes (“variants”) in one copy of the DNMT3A gene.
- Most variants are new (“de novo”), meaning they are not inherited, but inherited cases can occur from affected or mosaic parents.
- Mosaicism is when the genetic variant is present in only certain tissues or cell types of the body. Mosaic patients may have some characteristics of TBRS, but typically do not retain all symptoms
- Fully affected patients with TBRS have the variant in DNMT3A in all cells of their body.
- There is no identified risk factor or cause of de novo variants in DNMT3A.
- Diagnosis is through genetic testing
Laboratory Investigations
- Diagnosis involves a combination of genetic testing to identify pathogenic DNMT3A variants and identification of clinical symptoms.
- Additional screening tests may include:
- Height/weight/head circumference measurements
- MRI or brain imaging (to check for structural changes)
- Heart ultrasound (echocardiogram) for cardiac evaluation
- Developmental assessments
- Blood tests to screen for cancer risk
- Behavioral screening
- Orthopedic assessment
- Some tests, such as cardiac monitoring, may need to be repeated throughout life.
Treatment and Therapies
- No cure or specific treatments.
- Symptom management may include:
- Therapies: Physical, occupational, and speech therapy for mobility, speech, learning, and adaptive skills
- Behavioral interventions: Support for autism, anxiety, and other mental health concerns
- Medical support: For orthopedic (joints, spine), neurological (seizures), cardiac, or hematologic (blood) issues
- Educational support: Special education services as needed
- Family support: Connection to resources and support groups
- Medications may be used to help with specific symptoms (such as seizures or behavioral concerns), but options and decisions are individualized.
- Discuss all treatment options and medications with your doctor.
- Some individuals may need devices (such as orthotics) or surgery (for spine issues or cardiac defects).
- Regular check-ups and screening for complications are important.
Outlook
- Prognosis varies:
- Many individuals can make progress with development, especially with early intervention.
- Some may live independently with supports; others require help throughout life.
- Individuals with TBRS do not “grow out” of the disorder.
- Daily life may require planning for therapies, medical visits, and educational plans.
- Children may need accommodations at school to help them learn in the best way possible.
- Family life may change as the family adapts to support the child’s specific needs, but support and community resources are available.
- Diet and exercise may help with weight, but will not change the core features of TBRS.
Resources
The links and resources included in this section are solicited directly from the community by the Child Neurology Foundation through a formal submission process. CNF reserves the right to remove entities at any time if information is deemed inappropriate or inconsistent with the mission, vision, and values of CNF. The authors listed on this page have not endorsed the resources or links provided in this section.
Tatton Brown Rahman Syndrome (TBRS) Community
Our Mission
The Tatton Brown Rahman Syndrome Community aims to support all families affected by TBRS and advance research toward interventions.
Our Values
The Tatton Brown Rahman Syndrome Community is committed to developing a supportive, inclusive, and collaborative network of families, clinicians, researchers, and other stakeholders. We serve the patient above all else.
Our Goals
To create a comforting, inclusive community for diagnosed individuals and their families to connect, support each other, and share information.
To coordinate and support research on this newly identified, rare syndrome and identify treatments.
To educate the greater community and raise awareness of TBRS.
To manage a global patient registry for individuals diagnosed with TBRS.
Research
Currently, there are no listings for “Tatton Brown Rahman Syndrome” in ClinicalTrials.gov. Check back often and talk with your healthcare provider to identify upcoming trials.
If you have an interest in searching for any future trials that may be starting:
- Go to the Home page of ClinicalTrials.gov
- In the “Condition or disease” field, type “Disorder”. A drop-down list will appear if this disorder is included.
- You can narrow the search with the “Other terms”, “Intervention/Treatment”, and “Location” fields.
- Under “Study Status”, click on “Recruiting and not yet recruiting studies”.
- Click on “More Filters”, “Age”, “Child (birth - 17)”.
ClinicalTrials.gov is a database of privately and publicly funded clinical studies conducted around the world. This is a resource provided by the U.S. National Library of Medicine (NLM), which is an institute within the National Institutes of Health (NIH). Listing a study does not mean it has been evaluated by the U.S. Federal Government. Please read the NLM disclaimer for details.
Before participating in a study, you are encouraged to talk to your health care provider and learn about the risks and potential benefits.
Family Stories
The TBRS Community shares moving personal stories from individuals and families affected by the condition.
The information in the CNF Child Neurology Disorder Directory is not intended to provide diagnosis, treatment, or medical advice and should not be considered a substitute for advice from a healthcare professional. Content provided is for informational purposes only. CNF is not responsible for actions taken based on the information included on this webpage. Please consult with a physician or other healthcare professional regarding any medical or health related diagnosis or treatment options.
References
- Tatton-Brown K, Rahman N. Tatton-Brown-Rahman Syndrome. In: Adam MP, Everman DB, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 2015 May 18 [updated 2023 Apr 13]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK581652/7
- Tatton-Brown K, Seal S, Ruark E, et al. Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability. Nat Genet. 2014 Apr;46(4):385-8. doi: 10.1038/ng.2929.
- Gawlytta R, Grams B, Deland B, et al. Tatton-Brown-Rahman syndrome: Six individuals with novel features. Am J Med Genet A. 2020 Apr;182(4):826-833. doi: 10.1002/ajmg.a.61438.1
- Parfitt H, Lee J, Cloney C, et al. Expanding the genetic and clinical spectrum of Tatton‐Brown–Rahman syndrome. J Med Genet. 2024 Aug 29. pii: 38937076. doi: 10.1136/jmg-2024-109573.3
- National Organization for Rare Disorders (NORD). Tatton Brown Rahman Syndrome. RareDiseases.org. Updated 2025 Mar 5. Available from: https://rarediseases.org/rare-diseases/tatton-brown-rahman-syndrome/5
- TBRS Community. About TBRS. TBRSyndrome.org. Updated 2022 Sep 29. Available from: https://tbrsyndrome.org/about-tbrs/10
- Perplexity AI, Inc. Perplexity [Internet]. San Francisco (CA): Perplexity AI, Inc.; 2025 [cited 2025 Oct 24]. Available from: https://www.perplexity.ai
This overview is for general information and is not a substitute for advice from your child's care team.
← Back to the Disorder Directory